Source document
Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa (#09-038)
Has everything in it been taken?
CompleteReviewed 8 Oct 2026
Reviewed. Everything in it that belongs in the tables has been taken.
What the document holds
DOJ press release 09-038 (15 Jan 2009), Eli Lilly $1.415 billion over Zyprexa: criminal fine $515 million, forfeiture $100 million; civil up to $800 million (federal $438,171,544; states up to $361,828,456) resolving four qui tam actions in E.D. Pa. (ex rel. Rudolf, Faltaous, Woodward, Vicente, all former Lilly sales reps); relators receive $78,870,877; earlier $62 million state consumer-protection settlements (not programme). Already in the data: 1 case. Nothing added.
What it supports
1 row on this site come from this document. Each one opens with the page and the exact words.
About the document
What it covers Settlement announcement incl. federal share and (where stated) the relator share.
Notes Copy in raw/ is the Wayback Machine capture (archive_url); justice.gov served a bot-check page to scripted requests, not bypassed.
Source id usa-doj-pr-lilly-2009 · accessed 3 Oct 2026